ProCE Banner Activity

CE / CME

On-Demand Webcast: Integrating New Agents to Optimize Multiple Myeloma Care

Multimedia
In this archived Webcast from the 2017 CCO Multiple Myeloma Local Live meeting series, Raymond L. Comenzo, MD, provides expert perspective on integrating new agents and approaches into the treatment of patients with multiple myeloma.

Pharmacists : 0.75 contact {hour} ({0.075} CEUs)

Physicians : maximum of 0.75 AMA PRA Category 1 {Credit}

Registered Nurses : 0.80 Nursing contact {hour}

Released: November 29, 2017

Expiration: November 28, 2018

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Celgene

Karyopharm Therapeutics

Takeda Oncology

Target Audience

This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who care for patients with myeloma.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Integrate the newly approved monoclonal antibodies daratumumab and elotuzumab into existing treatment strategies for patients with MM
  • Describe laboratory testing interference and potential strategies to assess response to therapy when using monoclonal antibodies to treat patients with MM
  • Plan appropriate treatment strategies using the new-generation proteasome inhibitors carfilzomib and ixazomib for individual patients with MM
  • Apply data recently presented at major hematology/medical oncology meetings to clinical practice
  • Develop a proactive management plan for adverse events associated with new agents used to treat MM

Staff Disclosure

Staff

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley has no real or apparent conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.

Kristen Rosenthal, PhD

Clinical Editor

Kristen Rosenthal, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

0.8 contact hour may be earned for successful completion of this activity.

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

This program is assigned ACPE Universal Activity #0797-9999-17-121-H04-P. This program is designated for up to 0.75 contact hours (.075 CEUs) of continuing pharmacy education credit.

Type of Activity: Knowledge

For Pharmacists: Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 29, 2017, through November 28, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ competence in providing optimal care for patients with multiple myeloma.